- ¥6bn
- ¥3bn
- ¥3bn
- 45
- 32
- 33
- 27
Annual balance sheet for Morpho, fiscal year end - October 31st, JPY millions except per share, conversion factor applied.
2020 October 31st | 2021 October 31st | 2022 October 31st | 2023 October 31st | 2024 October 31st | |
|---|---|---|---|---|---|
| Period Length: | — | — | — | — | — |
| Source: | Yuho | Yuho | Yuho | Yuho | Yuho |
| Standards: | JAS | JAS | JAS | JAS | JAS |
| Status: | Final | Final | Final | Final | Final |
| Cash and Equivalents | |||||
| Cash and Short Term Investments | 4,437 | 3,392 | 3,060 | 2,712 | 2,936 |
| Net Total Accounts Receivable | |||||
| Net Total Receivables | 277 | 419 | 485 | 517 | 658 |
| Total Inventory | |||||
| Prepaid Expenses | |||||
| Total Other Current Assets | |||||
| Total Current Assets | 4,876 | 4,077 | 3,593 | 3,330 | 3,690 |
| Gross Property, Plant And Equipment | |||||
| Accumulated Depreciation | |||||
| Net Property, Plant And Equipment | 147 | 126 | 25.5 | 52.5 | 49.2 |
| Net Intangible Assets | |||||
| Long Term Investments | |||||
| Long Term Notes Receivable | |||||
| Other Long Term Assets | |||||
| Total Assets | 5,393 | 4,550 | 3,860 | 3,707 | 4,263 |
| Accounts Payable | |||||
| Accrued Expenses | |||||
| Notes Payable / Short Term Debt | |||||
| Current Portion of Long Term Debt / Capital Leases | |||||
| Total Other Current Liabilities | |||||
| Total Current Liabilities | 252 | 362 | 453 | 509 | 609 |
| Capital Lease Obligations | |||||
| Total Long Term Debt | |||||
| Total Debt | |||||
| Deferred Income Tax | |||||
| Minority Interest | |||||
| Total Other Liabilities | |||||
| Total Liabilities | 289 | 400 | 461 | 559 | 622 |
| Common Stock | |||||
| Additional Paid In Capital | |||||
| Retained Earnings (Accumulated Deficit) | |||||
| Treasury Stock | |||||
| Unrealized Gain / Loss | |||||
| Other Equity | |||||
| Total Equity | 5,105 | 4,150 | 3,399 | 3,149 | 3,641 |
| Total Liabilities & Shareholders' Equity | 5,393 | 4,550 | 3,860 | 3,707 | 4,263 |
| Total Common Shares Outstanding |